Rock Creek Pharmaceuticals Inc (RCPIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 1,704 | 1,448 | 1,069 | 425 | 401 |
| Cost of Goods | 1,008 | 743 | 624 | -691 | 1,574 |
| Gross Profit | 696 | 705 | 445 | 1,116 | -1,173 |
| Operating Expenses | 6,887 | 9,051 | 5,745 | 18,620 | 5,915 |
| Operating Income | -6,183 | -7,603 | -4,676 | -18,195 | -6,514 |
| Interest Expense | 0 | 0 | 0 | 56 | 63 |
| Other Income | 7,092 | -38 | -42 | 6 | 12 |
| Pre-tax Income | 909 | -7,641 | -4,718 | -18,245 | -6,565 |
| Net Income Continuous | 909 | -7,641 | -4,718 | -18,245 | -6,565 |
| Net Income Discontinuous | -543 | -355 | -453 | N/A | N/A |
| Net Income | $366 | $-7,996 | $-5,171 | $-20,340 | $-6,565 |
| EPS Basic Total Ops | 0.06 | -1.50 | -1.00 | -3.50 | -1.25 |
| EPS Basic Continuous Ops | 0.16 | -1.50 | -1.00 | -3.43 | -1.22 |
| EPS Basic Discontinuous Ops | -0.09 | -0.06 | -0.08 | N/A | N/A |
| EPS Diluted Total Ops | 0.06 | -1.50 | -1.00 | -3.50 | -1.25 |
| EPS Diluted Continuous Ops | 0.16 | -1.50 | -1.00 | -3.43 | -1.22 |
| EPS Diluted Discontinuous Ops | -0.09 | -0.06 | -0.08 | N/A | N/A |
| EBITDA(a) | $-6,099 | $-7,521 | $-4,593 | $-18,275 | $-6,424 |